2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow Healthy Subject: new trials by email Literature Review of Healthy Subject trials Research Report on Healthy Subject
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects STSA-1002 Injection, STSA-1005 Injection - Healthy Subject | Phase 1 | Terminated | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 50 | 2022-11-08 | 2024-05-22 |
| [18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers Fluorine F 18 DASA-23, Positron Emission Tomography - Healthy Subject, Intracranial Neoplasm | Phase 1 | Terminated | Guido A. Davidzon, MD, SM | 27 | 2018-04-23 | 2024-08-12 |
Brain Neoplasms (1) · Glioblastoma (1)
Astrocytoma (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Glioma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neuroectodermal Tumors (1)
Magnetic Resonance Spectroscopy (1)
Guido A. Davidzon, MD, SM (1) · Staidson (Beijing) Biopharmaceuticals Co., Ltd (1)
China (1) · United States (1)
Fengxue Guo, Bachelor (1) · Guido A Davidzon, MD (1)